United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Avita Medical (ASX: AVH) stock surges 25% after Europe clears Recell GO – but can momentum last? Avita Medical (ASX: AVH, NASDAQ: RCEL) stock soared 25% after CE Mark approval for RECELL GO in Europe. Explore how this milestone reshapes investor outlook. byPallavi MadhirajuSeptember 16, 2025